ES, SPY, SPX will be testing key support on Sunday After a welcome rally into new highs for the s&p, there appears to be a critical crossroad forming. Using the ES continuous contract I have placed 2 anchored VWAP's. The first being anchored to the last higher low on Thursday, June 19. And the the second, being anchored to this last Thursdays high on July 3rd.
For this post we will call the anchor from June 19 - VWAP1. And for the July 3rd anchor - VWAP2
VWAP1 r1 has acted as a key support line since the higher low was set. Successfully bouncing and holding support several times.
As we headed lower on this Thursdays July 3rd session, we remained between the center and r1 of VWAP2 indicating strong selling pressure for the day. With it being a shortened trading day with less liquidity however, I have less concern over the days price action. The forming crossroads and the upcoming Sundays open will be more telling for where we likely head this week.
The blue Horizontal Line at 6266 is placed directly on VWAP1s r1 (green line) which has acted as support. If we trade into this level on the Sunday open, it's a clear signal the sellers are still in control. If however, price can consolidate at that level (6266) and form structure, a breakout of the structure would be evidence of sellers backing off and buyers stepping in creating a good buying opportunity for the week.
Another possible scenario, if we first manage to trade up into s1 of VWAP2 (orange line) around the 6300 level, I will be looking for a short scalp down to the r1 of VWAP1 at 6266. From here it would be prudent to sit and wait for more confirmation on if this is a reversal, or just another pullback in the uptrend.
These are my two trade setups and ideas for Sunday's open. Hope this analysis helps. Happy trading 🤙💰📈
SPX (S&P 500 Index)
SPX500 Holds Above 6,225 – Bullish Trend Intact for NowSPX500 Update – Bullish Pressure Holds Above Pivot
SPX500 continues to show bullish momentum, as highlighted in our previous analysis. The price remains supported by strong buying volume above the key pivot zone at 6,225.
As long as the price stays above this level, a retest toward 6,225 remains possible before another leg higher.
However, a confirmed break below 6,225 would signal potential bearish momentum and shift the short-term structure.
Key Levels:
• Pivot Line: 6,246
• Resistance: 6,265 / 6,287 / 6,325
• Support: 6,225 / 6,191 / 6,143
S&P500: Once it breaks the 1W MA50, it doesn't look back.S&P500 has turned overbought on its 1D technical outlook (RSI = 75.570, MACD = 96.940, ADX = 23.950) and rightly so as it is extending the rally after crossing above the 1W MA50. The Channel Up since late 2011 shows that when the index crosses above its 1W MA50, it tends to spend a notable time over it (and every contact is a buy opportunity), with the most recent example being the March 2023 - December 2024 period. The shortest such period has been in 2019, which was suddently disrupted by the black Swan event of COVID. We may have gotten out of a similar situation as Trump's tariffs disrupted the uptrend earlier this year with a huge, unexpected correction. There 1W MA200 supported and this brings us to a new 'above the 1W MA50 bullish phase', which even if it is as short as 2019, it can still target 7,000.
See how our prior idea has worked out:
## If you like our free content follow our profile to get more daily ideas. ##
## Comments and likes are greatly appreciated. ##
SPX500 at New ATH – Will NFP Fuel the Next Leg Up? SPX500 Outlook: Trade Optimism Fades as Focus Shifts to U.S. Jobs Data
Caution prevails ahead of today’s high-impact U.S. Nonfarm Payrolls report, which could be pivotal for the July rate cut narrative. A weaker print may support risk assets and push SPX500 higher, while a strong report could dampen momentum.
Technical Analysis (SPX500):
SPX500 has printed a new all-time high and is now targeting 6287, especially if the index closes above 6246 on the 1H chart.
As long as price holds above 6225 (pivot), the bias remains bullish, with potential upside targets: 6287 & 6325
However, a 4H close below 6213 would suggest a correction toward: 6190 & 6143
Key Levels:
• Resistance: 6287 / 6325
• Support: 6190 / 6143
Stay alert — today's NFP report could trigger major moves across indices and FX.
July Doesn't Disappoint - S&P Nasdaq Dow Russell All RunningS&P All Time Highs
Nasdaq All Time Highs
Dow Jones closing in on All-Time Highs (and outperforming both S&P and Nasdaq recently)
Russell 2000 playing catch up and moving higher
This is melt-up at its finest
Since US/China Trade Agreement and Middle East Ceasefire Agreement, markets have used
these two events as further catalysts to continue the upside runs
Stochastic Cycle with 9 candles suggesting a brief pause or pullback in the near-term, but
a 3-5-10% pullback is still an opportunity to position bullish for these markets
I'm only bearish if the markets show that they care with price action. The US Consumer isn't breaking. Corporate Profits aren't breaking. Guidance remains upbeat. Trump is Pro Growth and trolling Powell on the regular to run this economy and market HOT demanding cuts (history says that's a BUBBLE in the making if it's the case)
Like many, I wish I was more aggressive into this June/July run thus far, but I'm doing just fine with steady gains and income trades to move the needle and still having plenty of dry powder
on the sidelines for pullbacks
Markets close @ 1pm ET Thursday / Closed Friday for 4th of July
Enjoy the nice long weekend - back at it next week - thanks for watching!!!
$SPX500 Most Hated Rally to Continue?FOREXCOM:SPX500 continues into price discovery suggesting a wave (3) is still underway but nearing a its minimum target of the 1.618 Fibonacci extension target $6310. Overextension of this target will demonstrate an even stronger bullish outlook.
Long term terminal targets remains above $7000 for me.
A short term pull back is a high probability but markets can stay irrational longer than participants can stay liquid.
Safe trading
DIYWallSt Trade Journal: Why Price Action Beats News **07/02/25 Trade Journal, and ES_F Stock Market analysis **
EOD accountability report: +763
Sleep: 4.5 hours
Overall health: sleep deprived
** VX Algo System Signals from (9:30am to 2pm) 4/4 success**
— 9:57 AM Market Structure flipped bullish on VX Algo X3! :check:
— 10:30 AM Market Structure flipped bullish on VX Algo X3! :check:
— 11:10 AM VXAlgo ES X1 Sell Signal :x:
**What’s are some news or takeaway from today? and What major news or event impacted the market today? **
You can't trade on news, the only thing that matters in day trading is price action.
Bad news can still make the market go up.
News
The U.S. economy lost 33,000 jobs in June, as per ADP, badly missing forecasts for a gain of 99,000.
MICROSOFT TO LAY OFF AS MANY AS 9,000 EMPLOYEES
Tesla’s NASDAQ:TSLA Q2 deliveries miss consensus expectations
**What are the critical support levels to watch?**
--> Above 6250= Bullish, Under 6240= Bearish
Video Recaps -->https://www.tradingview.com/u/WallSt007/#published-charts
10 Small-Cap Biotechs with Key Catalysts for 2025 July List________________________________________
🔬 10 Small-Cap Biotechs with Key Catalysts for 2025 July List
________________________________________
1. Allogene Therapeutics (NASDAQ: ALLO)
• Catalyst: Phase 2 data for ALLO-501A (anti-CD19 CAR-T for large B-cell lymphoma) expected in H2 2025; potential pivotal data could lead to regulatory submission.
• Highlights: “Off-the-shelf” allogeneic CAR-T approach could transform cell therapy; watch for manufacturing/scalability updates.
________________________________________
2. Lixte Biotechnology (NASDAQ: LIXT)
• Catalyst: Phase 2 combo trial of LB-100 (PP2A inhibitor) + immunotherapy in solid tumors, with key data expected in late 2025.
• Highlights: If efficacy signals emerge, could prompt partnerships or additional trials.
________________________________________
3. Iovance Biotherapeutics (NASDAQ: IOVA)
• Catalyst: Commercial launch and sales uptake for AMTAGVI (lifileucel, first FDA-approved TIL therapy in advanced melanoma); upcoming label expansion studies in lung and cervical cancer.
• Highlights: Investor focus on launch ramp, real-world data, and new trial initiations in 2025.
________________________________________
4. RenBio (NASDAQ: RENB)
• Catalyst: Phase 1/2 data for RB-100 (bispecific antibody platform in solid tumors) expected mid-to-late 2025.
• Highlights: Pipeline progress and partnership announcements possible.
________________________________________
5. IGM Biosciences (NASDAQ: IGMS)
• Catalyst: Phase 2 data for IGM-2323 (CD20 x CD3 bispecific in non-Hodgkin lymphoma) expected early 2025; ongoing updates from IgM antibody platform.
• Highlights: Investor interest in clinical safety, efficacy, and potential for big pharma tie-ups.
________________________________________
6. Zura Bio (NASDAQ: ZURA)
• Catalyst: Phase 2b/3 trial start and topline data for tibulizumab (IL-7Ra mAb for autoimmune diseases) expected late 2025.
• Highlights: Focus on rare and orphan autoimmune indications.
________________________________________
7. INmune Bio (NASDAQ: INMB)
• Catalyst: Phase 2 Alzheimer’s data (XPro1595, targeting neuroinflammation) and oncology pipeline updates expected H1 2025.
• Highlights: Any signal in Alzheimer’s is high-impact; monitoring for FDA guidance.
________________________________________
8. Veru Inc (NASDAQ: VERU)
• Catalyst: Phase 3 trial results for enobosarm (oral SARM) in advanced breast cancer expected 2025; also, COVID/sepsis drug updates.
• Highlights: Regulatory clarity and partnership/M&A rumors are potential drivers.
________________________________________
9. Century Therapeutics (NASDAQ: IPSC)
• Catalyst: First-in-human data for iPSC-derived NK and CAR-T cell therapies, with updates expected at major meetings in 2025.
• Highlights: Platform validation and early efficacy/safety signals.
________________________________________
10. ProKidney (NASDAQ: PROK)
• Catalyst: Phase 3 pivotal data for REACT (cell therapy for chronic kidney disease/diabetes) due late 2025.
• Highlights: If positive, could become the first autologous cell therapy for kidney disease.
________________________________________
🔎 How to Monitor These Catalysts
• FDA submissions/meetings (ALLO, PROK, VERU)
• Clinical trial readouts (LIXT, RENB, IGMS, ZURA, INMB, IPSC)
• Commercial/launch data (IOVA)
• Partnership/M&A activity (IGMS, VERU, RENB)
________________________________________
📊 Summary Table
Ticker Company Upcoming Catalyst/Event Timeframe
ALLO Allogene Therapeutics Phase 2 LBCL CAR-T pivotal data H2 2025
LIXT Lixte Biotechnology LB-100 + immunotherapy Phase 2 data Late 2025
IOVA Iovance Biotherapeutics AMTAGVI launch data; label expansions Throughout 2025
RENB RenBio Bispecifics Phase 1/2 data Mid-to-late 2025
IGMS IGM Biosciences IGM-2323 Phase 2 data (lymphoma) Early 2025
ZURA Zura Bio Tibulizumab Phase 2b/3 topline data Late 2025
INMB INmune Bio Alzheimer’s/oncology trial updates H1 2025
VERU Veru Inc Enobosarm Phase 3 (breast cancer) 2025
IPSC Century Therapeutics First-in-human iPSC cell therapy data 2025
PROK ProKidney REACT Phase 3 (CKD) pivotal readout Late 2025
________________________________________
⚠️ Word of Caution
Small-cap biotech stocks can be extremely volatile, especially around catalyst events (trial data, FDA decisions). Sharp price swings—both up and down—are common. Always conduct your own research and be aware of the risks.
S&P500 Bullish Leg not over yet.The S&P500 index (SPX) has been trading within a Channel Up since the May 07 Low and is currently unfolding the latest Bullish Leg.
As you can see, it is far from having topped, not just by a plain trend-line (Higher Highs) perspective but also based on the Fibonacci and % rise terms relative to the previous Bullish Leg.
That peaked after a +7.10% rise, a little above the 3.0 Fibonacci extension. As a result, a 6330 Target on the short-term is more than fitting.
-------------------------------------------------------------------------------
** Please LIKE 👍, FOLLOW ✅, SHARE 🙌 and COMMENT ✍ if you enjoy this idea! Also share your ideas and charts in the comments section below! This is best way to keep it relevant, support us, keep the content here free and allow the idea to reach as many people as possible. **
-------------------------------------------------------------------------------
Disclosure: I am part of Trade Nation's Influencer program and receive a monthly fee for using their TradingView charts in my analysis.
💸💸💸💸💸💸
👇 👇 👇 👇 👇 👇
SPX500 | Bulls Need Break Above 6225 to Regain ControlSPX500 | Market Overview
The price has reached the previously mentioned resistance level at 6225.
As long as it trades below 6225, a technical correction is likely, with downside targets at 6161 and 6143. From there, the index would need to stabilize above 6143 to resume a bullish structure.
However, a 1H candle close below 6143 would confirm a deeper bearish move toward 6098.
On the upside, a 1H close above 6225 would reinforce bullish momentum, with potential to reach 6250 and 6287.
Key Technical Levels
Pivot Level: 6191
Support: 6161 / 6143 / 6098
Resistance: 6225 / 6250 / 6287
S&P 500 Outlook. Best Quarter Since 2023… But What Next?The S&P 500 just logged its best quarterly performance since Q4 2023 , surging on optimism around global trade negotiations and growing expectations that the Fed may begin cutting rates as early as September. US futures are green this morning, thanks to developments like Canada backing off digital taxes, ongoing dialogues with China ahead of the July 9 deadline, and risk-on sentiment is pushing yields and the dollar lower.
But as traders, we need to ask:
Are we witnessing a genuine economic inflection point? Or is this just a liquidity-driven rally that’s pricing in a best-case scenario?
Technical View
Support Zone: 6,150 was just broken through. And 6000, the round number level, coinciding with the 20-day EMA and previous swing level.
Resistance Levels: 6,235 is the next critical ceiling, a clean breakout could see price reach the extension level of 6,415.
Momentum Indicators: RSI remains elevated and is creeping toward the overbought. While momentum is strong, watch out for the possible development of a divergence.
Possible Scenarios
The 'Soft Landing’ Is Now the Base Case
Markets are trading as if the Fed has successfully engineered a soft landing. But that’s now fully priced in, and historically, the most dangerous trades are the ones everyone agrees on. If trade talks stall, inflation re-accelerates, or earnings disappoint, the reversal could be brutal and fast.
Risk-on Sentiment Without Volume Is a Yellow Flag
Despite the price strength, volume has been tapering off. The S&P’s recent leg up occurred on lighter-than-average participation, suggesting institutions may be watching, not chasing. That’s often the case in low-volatility summers, but it also implies that any negative catalyst could cause outsized downside moves.
Macro-Fundamentals May Not Justify Valuation Expansion
Yes, inflation is slowing, and the Fed might cut. But if they do, it’s likely because growth is weakening, not because the economy is roaring. So the very condition that triggers rate cuts could also cap earnings growth!
Projection
Bullish Scenario: A confirmed breakout above 6,280 could carry us toward 6,400–6,500 by mid-Q3, especially if the trade deals progress, July inflation comes in soft, and the Fed signals accommodation.
Bearish Risk: If price fails to hold above 6,120, especially if trade optimism fades, or inflation growth spikes or Fed rhetoric shifts hawkish again, this could then open a quick pullback toward 6,000 or lower, which also aligns with the 50-day SMA.
Key Events to Watch
July 9 Trade Talks Deadline: Any sign of stalling could bring volatility back fast.
June CPI Print (July 10): Crucial for confirming the Fed's next move.
Earnings Season Kickoff (mid-July): Tech-heavy expectations may not be easy to beat after such a strong run.
Conclusion
A record-setting quarter is impressive but not necessarily predictive. This quarter’s rally has been built more on relief and expectations than hard data. When expectations (not earnings) are doing the heavy lifting, any misstep from central banks or geopolitics could unravel gains rapidly.
A rate cut might be delayed, or inflation re-accelerates, or trade talks stall; any of these could leave equities hanging. Remember: the higher the climb without real earnings growth, the harder the fall when sentiment shifts. It's not just about the chart. It is about the narrative behind the price.
What’s your bias for Q3?
Are you buying this breakout or fading the optimism? Drop your thoughts below.
Possible "DIP" into Monday July 7 Tarrif DeadlineHello everyone,
Well we made it. ATH! Well all things must eventually dip. I see a good possibility into next Monday July 7 Tarif deadline plus we are hitting the ATH's prior tops trendline (Red Line)....
I highlight with colored boxes 3 different price targets I think it could dip to before resuming its march higher.
Let's see what happens!
SPY S&P 500 ETF Potential W-Shaped Recovery Forming We may be witnessing the formation of a W-shaped recovery on the SPY (S&P 500 ETF) – a classic double-bottom structure that often signals a strong reversal after a period of correction or volatility. Let’s dive into the technicals and what this could mean in the sessions ahead.
🔍 The Technical Setup:
SPY recently tested key support around the $485-$500 zone, bouncing off that area twice in the past few weeks. This gives us the left leg of the W and the first bottom. After a modest relief rally to ~$520, we saw another pullback – but this second dip failed to break below the first bottom, a hallmark of the W-pattern.
As of today, SPY is starting to reclaim ground toward the $517-$520 resistance zone. If bulls can push through this neckline area, especially with volume confirmation, we could see a breakout that targets the $530-$535 area in the short term.
🔑 Key Levels to Watch:
Support: $490-$500 (double-bottom support zone)
Neckline/Resistance: $530
Breakout Target: $550 (previous highs)
Invalidation: A break below $490 with volume could invalidate the W-recovery idea and shift bias bearish.
📊 Momentum & Volume:
RSI is climbing back above the 50 level – bullish momentum building.
MACD shows a potential crossover forming, hinting at a shift in trend.
Watch for increasing buy volume as SPY approaches the neckline – that’s where the bulls will need to step up.
🧠 Macro & Earnings Angle:
Don’t forget – we’re entering a heavy earnings season and rate cut expectations are still a wildcard. A dovish tone from the Fed and strong corporate results could be the fuel that sends SPY higher to complete this W-shaped recovery.
🧭 Final Thoughts:
This is a high-probability setup if neckline resistance is broken cleanly. Wait for confirmation before going heavy – fakeouts are common in double-bottom scenarios. If we do get the breakout, we may be looking at a broader market rebound going into summer.
🔔 Set alerts near $525. A confirmed breakout could mean the bulls are back in charge.
06/30/25 Trade Journal, and ES_F Stock Market analysis
EOD accountability report: +212
Sleep: 7 hours
Overall health: Good, caught up on workout and sleep over the weekend.
** VX Algo System Signals from (9:30am to 2pm) 2/4 success**
— 12:20 PM VXAlgo NQ X1 Sell Signal :x:
— 12:30 PM Market Structure flipped bullish on VX Algo X3!:check:
— 1:55 PM VXAlgo NQ X1 Buy Signal :x:
— 2:00 PM Market Structure flipped bearish on VX Algo X3! :check:
**What’s are some news or takeaway from today?
and What major news or event impacted the market today?
**
The X1 Signals today has been happening after market structure signals and usally that means MM is going to change the direction to the opposite way to scam us. Based on that, I decided to lock out my account after making $200 today so i don't get caught in the scam.
News
EU TO ACCEPT TRUMP’S UNIVERSAL TARIFF BUT SEEKS KEY EXEMPTIONS — 2:07 PM
What are the critical support levels to watch?
--> Above 6240= Bullish, Under 6210= Bearish
Video Recaps -->https://www.tradingview.com/u/WallSt007/#published-charts
Stocks Are Crushing It at Record Highs. What’s Behind the Rally?Happy record highs, everyone — confetti, champagne, and yet another all-time high. The Nasdaq NASDAQ:IXIC and the S&P 500 SP:SPX just did it again — notched fresh closing records that have traders flexing their P&Ls like it’s 1999.
If you’ve been on the sidelines, you’re probably staring at the chart asking: How did we add trillions to market cap while my grocery bill still looks like a high-yield bond payment?
Good question. Because these days, stocks are behaving like they live on a separate planet from the actual economy (looking at you, Nvidia NASDAQ:NVDA ).
Let’s pop the hood and see what’s revving this record-breaking machine — and what potholes might lurk ahead.
🤫 Nasdaq: The Comeback Kid of 2025
Take the Nasdaq Composite NASDAQ:IXIC — your favorite tech playground — up a mind-boggling 32% since the April lows . One-third of its total value was minted in three months — as much as $7 trillion added in.
What happened? Well, start with the obvious: the Magnificent Seven are doing the heavy lifting again. Nvidia NASDAQ:NVDA , Microsoft NASDAQ:MSFT , Apple NASDAQ:AAPL , Amazon NASDAQ:AMZN , Alphabet NASDAQ:GOOGL , Meta NASDAQ:META , Tesla NASDAQ:TSLA — they’re the gym rats of this rally.
But here’s the kicker: while the headlines are all “index record highs,” the Mag 7 as a whole are actually down slightly for the year. The hero’s cape belongs mostly to a few standouts: Meta, up 21% this year. Microsoft, up 17%. And Nvidia? Not bad: up a whopping 65% since the April swoon.
When the generals lead, the army follows — at least until they don’t?
🤖 S&P 500: Powered by 7, Dragged by 493
The broad-based S&P 500 also clocked a new record close at 6,173.07 . Everyone loves to toast a new all-time high, but here’s your buzzkill: the “500” in S&P 500 is a bit of a myth these days.
The Magnificent Seven alone account for more than 30% of the index’s total weight. Last year, this elite club rose 57% while the other 493 stocks crawled up just 13%. Strip out the hyper-scalers, and you’ll find most stocks are still limping along, wrestling with tepid growth and stubborn inflation.
So yes — the S&P 500 is soaring. But the S&P 493? Not partying at the same rooftop bar.
💼 Conflicting Data: This Economy Ain’t It (Yet)
Here’s where it gets spicy: GDP actually shrank last quarter — down 0.5% year over year. Inflation is still running hot with May’s PCE figure at 2.7% (the Fed’s target is 2%).
Fed boss Jay Powell and the central bank squad are trying to thread the world’s tiniest policy needle: cut rates enough to juice the economy, but not so much that they stoke a fresh inflation flare-up.
Meanwhile, job numbers are a mixed bag , and corporate revenue hasn’t been setting new records to match those ceiling-high stock valuations.
In short, the disconnect between equity prices and economic reality is growing wider than the spread on your favorite meme coin during an illiquid Sunday afternoon.
👨🏻💻 Tariffs, Tweets, and the Trump Factor
And who could forget the wildcard factor? Trump’s new tariffs. The “reciprocal tariffs,” as he likes to pitch them. One day he’s threatening to slap 50% duties on everything from French wine to German cars. The next, he’s cozying up for “productive” chats with Brussels.
This policy whiplash makes supply chains sweat, but so far, equity traders are shrugging it off — and even cheering. Why? Because in Trump’s world, chaos means central banks might cut rates to cushion the blow. And nothing says “rocket fuel” for risk assets like lower borrowing costs.
Add to that the weird paradox that tariffs — while inflationary in the short run — can also weaken the dollar if the Fed turns dovish. A weaker greenback means US tech giants look cheaper to global investors. So… up we go.
🏛️ The Great Fed Cut Watch
Speaking of cuts: the Fed’s next meeting is in late July, and Wall Street is holding its breath. Rate cuts mean cheaper money — which often means traders load up on risk.
The market is currently pricing in a 90% chance of a cut in September (and an 80% chance of a hold in July). Meanwhile, gold OANDA:XAUUSD — the non-yielding safe haven — is selling off while traders are flocking toward the risk-end of the boat, leaving the safe-haven corner gathering dust.
👀 What’s Next? The Inevitable Hand-Wringing
So — should you pop champagne? Depends.
If you’re a trend follower, record highs are record highs. Momentum is your friend. But if you’re a value purist, these multiples probably make your eye twitch.
Big question: when does this all get too frothy? Will the next earnings season justify these valuations? Markets are forward-looking anyway — even if big tech’s revenue flops, that doesn’t mean money will flow out of the market cap.
After all, we’re halfway through the year and that means it’s time to pop open the Earnings calendar for those spring reports.
Any dip right now may very well be seen as an opportunity to swoop in at a lower price, not as something that indicates there’s something fundamentally wrong with the business.
🫶🏻 The Takeaway: Celebrate, but Stay Focused
The rally is real. The headlines are dazzling. But the same lessons apply: trends don’t last forever, risk doesn’t disappear just because the chart is green, and the Magnificent Seven won’t carry the world on their backs indefinitely.
So have your stop losses placed right, your position sizes sensible , and your eyes on the macro backdrop. Because record highs are fun, but holding the bag isn’t.
Off to you : Are you riding this rocket or waiting for the next dip? Drop your take below — are we so back, or about to crack?
SPX500 Extends Rally on Fed Hopes and China Trade DealS&P 500 Set to Extend Record Highs
U.S. stock futures climbed on Friday, continuing this week’s strong momentum on hopes of eased trade tensions and growing confidence in multiple Fed rate cuts later this year.
Futures tied to the S&P 500 and Nasdaq 100 pointed to fresh record-high openings, while the Dow Jones was set to rise by 150 points.
Adding to the bullish tone, Commerce Secretary Lutnick announced a trade agreement with China, reducing tariff risks and easing concerns over rare earth shortages.
TECHNICAL OUTLOOK – SPX500
The index has broken into new all-time highs (ATH) and stabilized above the 6,143 resistance level, confirming bullish strength.
As long as the price trades above 6,143, the uptrend is likely to continue toward 6,225, with potential short-term pullbacks to 6,143.
A 1H candle close below 6,143 could trigger a deeper correction toward the pivot zone at 6,098.
Key Levels
Resistance: 6,175 → 6,225
Support: 6,098 → 6,041
previous idea:
SPX: new ATH, despite allEconomy, geopolitics, trade tariffs, inflation, Fed moves. It seems that the market got tired of all news during the previous period, and decided to take the optimistic side, despite all. The S&P 500 reached a fresh, new all-time highest level on Friday's trading session, at 6.185. With the latest move, the S&P 500 managed to erase all losses from April this year, when the index tumbled around 20% after the implementation of trade tariffs.
The weekly trade tariffs news brought a termination of talks between the U.S. and Canada. However, what moved the market the most was the news that the US Administration settled a deal on trade tariffs with China. Although details of the deal were not publicly disclosed, still the market reacted very optimistic about it.
At the same time, the latest macro figures for the US are showing that the tariffs are slowly starting to reflect in the U.S. economy. The Fed's favorite inflation gauge, the PCE index increased by 0,1% in May, which was expected. However, the Personal Income and Personal Spending in May missed heavily market estimates. The Personal Income dropped by -0,4% for the month, while Personal Spending dropped by -0,1%. Analysts are pointing that these figures are showing that the US consumers are spending less due to increased prices of goods, after implementation of tariffs. At the same time, there was a slowdown in the U.S. GDP growth rate, final for Q1 was negative for the quarter, at the level of -0,5%.
Tech companies continued to be in the focus of investors' interest. APPL closed the week at $210,08, with a modest weekly gain of 0,24%. MSFT gained 3,87% for the week, closing it at $495,94. Market favourite NVDA surged by 9,74% within a week, closing at $157,75. AMZN also had a good week with a surge of 6,33%. Despite higher volatility, TSLA ended the week at 0,33% higher, underperforming other tech companies included in the index.
SP500 - Cycle Analysis; New V-Bottom24 Dec 2018 - V-Bottom Trough:
This marks a clean V-bottom. Both the 227-ROC and 114-ROC showed simultaneous positive acceleration after price reacing its low. Shortly after, both crossed their 57-SMA almost in sync — increasing the probability of a sustained bullish move. Price confirmed this by breaking resistance and forming a V pattern. This was further validated by the centered moving average crossover (114-CMA crossing above 227-CMA).
25 Mar 2020 - Deep COVID Crash Trough:
During this phase the priced broke below the support, creating a deep trough. Altough both ROC lines initially showed strong negative acceleration due to the COVID-19 crash, they soon reversed above their 57-SMAs, signaling a major shift in momentum. This coincided with the price breaking above the key resistance which was also crossed in 2019 when confirming the old V-pattern. After this breakout, a brief pullback followed before the uptrend resumed with increasing strength.
22 Jun 2021 to 19 Dec 2023 - Pattern
During the initial period a bearish divergence was visible in the ROC, nevertheless price and rate of change both declined making a low in early October 2022. A technical pattern began to form, which appears to align more closely with a symmetrical triangle; So when measuring its height and projecting it from the breakout point aligns with the new all-time highs that were reached on 27 June 2025.
21 Mar 2025 - New Cycle Trough
A new V-bottom formed shortly after the current cycle began. Both ROC indicators had already crossed their SMAs to the upside, showing early signs of positive acceleration, days before of price broke through the resistance and reached the new record high.
The 227-SMA is likely to cross from below the fast SMA while a possibility of a pullback increase.
Following that, the 114-CMA will probably has the chance to cross back the 227-CMA, with the price potentially confirming a new support level and resuming its uptrend - in line with the broader cycle timeline.
$SPX Path of least resistance is higher. Next Stop : 6500 This week we officially recovered all the losses from the liberation day low. We had a 20% bear market crash and since then there has been a V shaped rally in the major averages. NASDAQ:QQQ and SP:SPX have fully recovered the losses and then some. It is 0% form its ATH. We have been closely following the chart of SP:SPX for the last few weeks and have marked various Fib Retracement levels and Fib Extenstion. IN my opinion the Covid lows were one of the majot drawdown moments.
If we plot the Fib Extension on the COVID highs and lows, we can clearly see the Support and Resistance zones. As per the Fib Levels the next consequential level in SP:SPX will be 6550, which is the 3.618 Fib level. That I would suggest as the path to least resistance. First, we go higher before we can see any major correction. In case of a Major correction, we get support @ 5300.
Verdict : SP:SPX goes higher first before correction. 6550 is the next stop.
BRIEFING Week #26 : Are we going for a Bubble ?Here's your weekly update ! Brought to you each weekend with years of track-record history..
Don't forget to hit the like/follow button if you feel like this post deserves it ;)
That's the best way to support me and help pushing this content to other users.
Kindly,
Phil